TY - JOUR T1 - Chronic disease as risk multiplier for disadvantage JF - Journal of Medical Ethics JO - J Med Ethics DO - 10.1136/medethics-2017-104321 SP - medethics-2017-104321 AU - Francisca Stutzin Donoso Y1 - 2018/03/06 UR - http://jme.bmj.com/content/early/2018/03/05/medethics-2017-104321.abstract N2 - This paper starts by establishing a prima facie case that disadvantaged groups or individuals are more likely to get a chronic disease and are in a disadvantaged position to adhere to chronic treatment despite access through Universal Health Coverage. However, the main aim of this paper is to explore the normative implications of this claim by examining two different but intertwined argumentative lines that might contribute to a better understanding of the ethical challenges faced by chronic disease health policy. The paper develops the argument that certain disadvantages which may predispose to illness might overlap with disadvantages that may hinder self-management, potentially becoming disadvantageous in handling chronic disease. If so, chronic diseases may be seen as disadvantages in themselves, describing a reproduction of disadvantage among the chronically ill and a vicious circle of disadvantage that could both predict and shed light on the catastrophic health outcomes among disadvantaged groups—or individuals—dealing with chronic disease. ER -